Phlow and Enveda Partner to Advance AI-Driven Chemistry to Accelerate Domestic Pharmaceutical Development and Transform Drug Substance Manufacturing

RICHMOND, Va., January 14, 2026 – Phlow Corp., a leading American pharmaceutical contract development and manufacturing organization (CDMO), today announced a major advancement in AI-driven Active ...
Contract Pharma

Phlow, Enveda Share Progress on AI-Powered API Manufacturing Collaboration

Enveda has been using AI to power its drug discovery platform for several years. The company injected $230 million into ...
News Medical

Lab to plant: Scaling up API processes with Dr. James Mencel's guidance

In this interview, NewsMed talks to Dr. James Mencel's Guidance about Scaling Up API Processes. Could you introduce yourself and your experience in the pharmaceutical industry? I obtained a B.S. in ...
PharmTech

Improving the Sustainability of API Manufacturing with Recycling Technologies

Sustainability of small-molecule API manufacturing ensures continued success. Improving the sustainability of small-molecule API manufacturing is essential to ensuring the continued success of the ...
PharmTech

Advancing Pharmaceutical Quality through Integrated Digital Systems and Collaborative Scientific Innovation

PharmTech recently spoke with Saharsh Davuluri, Vice Chairman and Managing Director, Neuland Labs, to get his perspective on trends that shaped pharmaceutical development and manufacturing in 2025 and ...
Yahoo Finance

Biotech API Manufacturing Services Market to Surpass US$ 73 Bn by 2031 | Driven by Rising Demand for Biologics & Personalized Medicine – Latest Report by TMR

The global biotech API manufacturing services market, valued at US$ 38.9 Billion in 2022, is projected to grow at a CAGR of 7.1% from 2023 to 2031, surpassing US$ 73 Billion by 2031. biotech API ...